Skip to main content
. 2012 Oct 19;13:271. doi: 10.1186/1471-2105-13-271

Table 4.

Suggested predictions for experimental validation.

Gene Symbol Chr Str SNP(rs#) Location Posterior SS FDR Group
CCDC148
chr2
+
17492855
158989711
0.999999314
18
0.014
II
BAT1
chr6
-
3093976
31610839
0.999930191
8
0.12
II
PEBP1
chr12
+
1051470
117067614
0.999873859
14
0.051
II
LOC100130955
chr14
+
11160608
100382845
0.999795515
20
0.023
II
RPL10AP6
chr3
+
584959
61703763
0.999517203
11
0.055
II
KCNJ12
chr17
+
16962951
21259999
0.998953843
11
0.055
II
VARS2
chr6
+
1043483
31001706
0.998607936
14
0.051
II
BAT2
chr6
-
2272593
31709322
0.998223631
9
0.052
II
RPL10AP6
chr3
+
584959
61703763
0.995668725
9
0.052
I
KDM5B
chr1
+
10800864
201003241
0.995398014
9
0.052
I
TAPBP
chr6
-
1059288
33375649
0.995270134
13
0.057
II
KCNQ5
chr6
-
2000203
73753786
0.993101795
13
0.069
II
FER
chr5
+
2009646
108148856
0.989758091
6
0
I
LOC643534
chr5
+
2009646
108148856
0.989758091
6
0
I
LY6G5B
chr6
-
1266076
31748496
0.98719144
16
0.028
II
NOMO2
chr16
+
7179
14897344
0.979473344
7
0
II
BAT5
chr6
-
1475865
31765391
0.979015507
7
0
II
RXRB
chr6
-
6531
33271428
0.977747582
6
0
II
FER
chr5
+
2009646
108148856
0.962143895
6
0
II
ZBTB22
Chr6
-
1061783
33390605
0.96804794
12
0.076
II
LOC283398
chr12
-
3827521
93467186
0.908227908
7
0
I
UCRC
chr22
+
14115
28493525
0.889141351
15
0.039
II
MT2A
chr16
+
10636
55200843
0.709333922
10
0.142
II
RQCD1
chr2
+
526897
219141840
0.683651187
13
0.128
II
PSMC3IP
chr17
-
6963
37985122
0.661403579
12
0.146
II
CSTF3
chr11
-
1028564
33118584
0.479199531
8
0.373
II
LOC100128252
chr19
+
3971706
61697880
0.478128233
4
0.343
I
LOC100130814
chr14
-
2295655
100608883
0.446498085
18
0.228
II
IMPDH1
chr7
-
2228075
127821864
0.283348511
17
0.318
II
CLDN4 chr7 + 1127155 72884396 0.270700082 4 0.594 I

Boldface indicates proximity to known imprinted genes. Underline indicates a gene has multiple (≥3) SNPs with posteriors > 0.2. Genes are sorted by their posteriors. RPL10AP6 and FER are listed for both Group I and Group II. Abbreviations are the same as in Table 2.

HHS Vulnerability Disclosure